Recent Experience
Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of units of Medivolve Inc. for aggregate gross proceeds of $5 million.
Canaccord Genuity Corp., as lead agent, in the brokered private placement of units and flow-through shares of NioBay Metals Inc. for aggregate gross proceeds of $11.5 million.
ECI Software Solutions, in its acquisition of Shoptech Industrial Software Corp., a provider of ERP software for job shops and made-to-order manufacturers.
Dye & Durham Limited, a leading provider of cloud-based software and technology solutions for legal and business professionals, in its $530-million acquisition of DoProcess LP, an Ontario-based provider of practice-specific software for legal professionals, from OMERS Infrastructure.
Institutional investors advised by JP Morgan Asset Management in the acquisition of Contanda, a provider of bulk liquid storage and logistics services, from EQT Infrastructure II Fund
Kensington Capital Partners and Kensington Private Equity Fund, in the $35-million acquisition and related financing through its portfolio company, Clearpoint Health Network Inc., of the surgical and medical centres business of Centric Health Corporation, a TSX listed company, and subsequent reorganization of Clearpoint. Kensington Capital Advisors Inc. is a leading independent investor in alternative assets with over $1.5 billion invested in private equity and alternative assets.
Cresco Labs Inc., in its acquisition of Tryke Companies, including the Reef Dispensary Portfolio, for US$252.5 million for Tryke operating assets plus US$30 million for Tryke real estate assets.
Cresco Labs Inc., in a public offering of 7,350,000 units at a price per unit of $10.00 for gross proceeds of $73,500,000.
District Ventures, in its equity investment in seven companies as part of its accelerator program.
ECi Software Solutions Inc., in its acquisition of Print Audit.
ECi Software Solutions Inc., in its acquisition of Lasso Data Systems.
Gold Flora, LLC, in its private placement offering of debenture units for aggregate gross proceeds of over US$14 million.
TerrAscend Corp., in its non-brokered private placement of common shares for aggregate gross proceeds of approximately $69 million.
ECi Software Solutions Inc., a leader in industry-specific information technology solutions, in its acquisition of PrintFleet Inc.
Cresco Labs, in its $1.1-billion acquisition of Origin House.
A syndicate of agents, led by Canaccord Genuity Corp., in the brokered private placement of units of LiveWell Foods Canada Inc. for aggregate gross proceeds of $10 million.
Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of special warrants of CLS Holdings USA, Inc. for aggregate gross proceeds of $13 million.
Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of convertible debentures of Central Coast Agriculture, Inc. for aggregate gross proceeds of up to US$25 million.
A syndicate of agents, led by Canaccord Genuity Corp., in the brokered private placement of convertible debentures of CLS Holdings USA, Inc. for aggregate gross proceeds of up to US$20 million.
Cresco Labs LLC, in its $2.2-billion reverse takeover transaction and public listing on the Canadian Securities Exchange.
Toronto-based FlashStock Technology Inc., in its sale to Shutterstock, Inc., a leading global provider of commercial digital imagery, for approximately US$50 million.
District Ventures, in formation of venture capital fund and fund investments in companies in the consumer packaged goods industry.
Special Committee of Halogen Software Inc., in a $293-million acquisition by way of plan of arrangement.
Opus One Energy Solutions, in a financing by two U.S.-based venture capital investors.
Clearpath Robotics, in numerous matters, including financings that included Canadian and U.S.-based venture capital investors.
Book4Time, in financing matters.
OMERS Ventures LP, in its participation in the $6 million Series A funding round of Fusebill Inc.
Fluorinov Pharma Inc., a privately-held oncology company, in its $10-million acquisition by Trillium Therapeutics Inc.
Park Lawn Corporation, in the $24.2-million bought deal prospectus offering of 2,105,400 subscription receipts in December, 2015 - Counsel to syndicate of underwriters led by National Bank Financial Inc.
Bennett Jones
